elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Head and neck cancer
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Head and neck cancer
RIS
0.002
(Research Intensity Score)
Papers
223
Top papers
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
2025 · 313 citations
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
2019 · 3244 citations
NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse.
2025 · 58 citations
Head and Neck Cancer
2025 · 43 citations
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
2018 · 1703 citations
Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial
2022 · 204 citations
Immunotherapeutic strategies in head and neck cancer: challenges and opportunities
2025 · 35 citations
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
2019 · 743 citations
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
2016 · 5107 citations
Newest papers
Hypofractionated Versus Normofractionated Accelerated Radiation Therapy With or Without Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma (HYPNO): A Randomized, Open-Label, Phase 3, Noninferiority Trial
2026 · 5 citations
Intratumoral Radioenhancer Nanoparticle NBTXR3 Followed by Radiotherapy in Head and Neck Cancer
2026 · 5 citations
Radiation-induced remodeling of the T cell landscape in head and neck cancer
2026 · 3 citations
Correlation of tumor maximum standardized uptake value from 18F-BPA PET and boron neutron capture therapy tumor dose with treatment outcomes in head and neck cancer: a retrospective analysis
2026 · 2 citations
Impact of combined positive score in cetuximab plus chemotherapy in recurrent/metastatic head and neck cancer: A real-world study
2026
Curcumin-Based Adjuvant Strategies in Head and Neck Cancer: Synergistic Mechanisms and Translational Perspectives
2026
Cost-effectiveness analysis of finotonlimab in the treatment of advanced recurrent metastatic head and neck squamous cell carcinoma in China
2026
Incidence, Mortality, Sex Differences, and Demographic Projections for Six Selected Head and Neck Cancer Site Groups in Indonesia: A Secondary Analysis of GLOBOCAN 2024 Modeled Estimates
2026
Simultaneous Integrated Boost Versus Sequential Boost Chemoradiotherapy Induced Toxicity and Its Association with Oral Candidiasis in Locally Advanced Head and Neck Cancer
2026
Browse all papers →
Head and neck cancer's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Head and neck cancer's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link